In-vitro activity of lansoprazole against Helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 585-590

  Figura, Natale ^a,d   Crabtree, Jean E ^b   Dattilo, Maurizio ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c Cyanamid Italia SpA   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; STOMACH SECRETION INHIBITOR; SULFENAMIDE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL VACUOLE; CONTROLLED STUDY; HELA CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STOMACH PARIETAL CELL; STRAIN DIFFERENCE; TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-BACTERIAL AGENTS; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; PROTON PUMPS; VACUOLES;

EID: 0031008895     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.585     Document Type: Article

References (20)

1. Figura, N., Bugnoli, M., Armellini, D. & Crabtree, J. E. (1994). Activities of omeprazole and lansoprazole against Helicobacter pylori in-vitro. Hepato-Gastroenterology 41, 92-3.
2. Iwahi, T., Satoh, H., Nakao, M., Iwasaki, T., Yamazaki, T., Kubo, K. et al. (1991). Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrobial Agents and Chemotherapy 35, 490-6.
3. Bugnoli, M., Bayeli, P. F., Rappuoii, R., Pennatini, C., Figura, N. & Crabtree, J. E. (1993). Inhibition of Helicobacter pylori urease by omeprazole. European Journal of Gastroenterology and Hepatology 5, 683-5.
4. Nagata, K., Satoh, H., Iwahi, T., Shimoyama, T. & Tamura, T. (1993). Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrobial Agents and Chemotherapy 37, 769-74.
5. Cover, T. L. & Blaser M. J. (1992). Purification and characterization of the vacuolating toxin from Helicobacter pylori. Journal of Biological Chemistry 267, 10570-5.
6. Figura, N., Guglielmetti, P., Rossolini, A., Barberi, A., Cusi, G., Musmanno, R.A. et al. (1989). Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. Journal of Clinical Microbiology 27, 225-6.
7. +-ATPase of gastric cells. A target of Helicobacter pylori cytotoxic activity. FEBS Letters 334, 158-60.
8. Figura, N., Armellini, D., Bugnoli, M., Bayeli, P. F., Gennari, C. & Crabtree, J. E. (1994). Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains. Journal of Clinical Pathology 47, 440-2.
9. Simon, A., Besançon, M., Shin, J. M. & Sachs, G. (1993). The H,K ATPase sites that react selectively with the benzimidazole class of anti-ulcer drugs. Gastroenterology 104, 4 Suppl., A192.
10. +)-adenosine triphosphatase by the proton pump inhibitor AG-1749. Journal of Pharmacology and Experimental Therapeutics 248, 799-805.
11. Sachs, G., Shin, J. M., Besançon, M. & Prinz, C. (1993). The continuing development of gastric acid pump inhibitors. Alimentary Pharmacology and Therapeutics 7, Suppl. 1, 4-12.
12. Papini, E., Bugnoli, M., De Bernard, M., Figura, N., Rappuoli, R. & Montecucco, C. (1993). Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Molecular Microbiology, 7, 323-7.
13. Lage, A. P. & Glupczynski, Y. (1994). Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negative Helicobacter pylori strains and does not inhibit vacuolating toxin production. European Journal of Gastroenterology and Hepatology, 6, 299-301.
14. Mauch, F., Bode, G. & Malfertheiner, P. (1993). Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. American Journal of Gastroenterology 88, 1801-2.
15. Mégraud, F., Boyanova, L. & Lamouliatte, H. (1991). Activity of lansoprazole against Helicobacter pylori. Lancet 337, 1486.
16. Helander, H. F., Ramsay, C. H. & Regard, C. G. (1985). Localization of omeprazole and metabolites in the mouse. Scandinavian Journal of Gastroenterology 20, Suppl. 108, 95-104.
17. Sekiguchi, M., Nagaya, H., Satoh, H. & Shino, A. (1992). Localization of a novel proton pump inhibitor, lansoprazole, in the gastric mucosa of the rat: an autoradiographic study. Acta Histochemica et Cytochemica 25, 405-10.
18. Williams, C., Preston, T., Slater, C., Hossack, M. & McColl, K. E. L. (1995). H. pylori uses urea for amino acid synthesis at neutral pH. Gut 37, Suppl.1, Abstract A247, p. A62.
19. Eaton, K. A., Brooks, C. L., Morgan, D. R. & Krakowka, S. (1991). Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infection and Immunity 59, 2470-5.
20. Figura, N., Crabtree, J. E. & Dattilo, M. (1995). Antimicrobial activity of lansoprazole against Helicobacter pylori in-vitro and relation with cytotoxin production of strains. Gut 37, Suppl. 1, Abstract A183, p. A46.